Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

People In Brief

This article was originally published in The Gray Sheet

Executive Summary

New HRS president: N. A. Mark Estes, III, M.D., is the new president of the Heart Rhythm Society, taking the helm from Bruce D. Lindsay, M.D., Cleveland Clinic, at HRS' annual conference in San Francisco, May 17. Lindsay recently left Washington University in St. Louis to become director of electrophysiology at the Cleveland Clinic office (1"The Gray Sheet" Jan. 28, 2008, p. 19). Estes is chief of the Cardiac Arrhythmia Center at the New England Medical Center Hospital in Boston and a professor at Tufts University School of Medicine

You may also be interested in...



People In Brief

CDRH's revolving associate directors: Mark Raza is returning to the FDA Office of Chief Counsel after serving as CDRH's acting associate director for regulation and policy for the past six months. Kate Cook, an associate chief counsel for biologics in the chief counsel's office, will be joining CDRH for a four-month detail in the vacated position

Hologic/Cytyc Merger Combines Diverse Women’s Health Device Portfolios

The combination of mammography device maker Hologic and cervical cancer test firm Cytyc will create a women's health powerhouse with $1.44 billion in combined annual revenues

Second Judge Rejects Constitutional Challenges To Medicare Price Negotiation Program

Delaware district judge rules against AstraZeneca’s claim the IRA violates its due process rights, echoing findings made by Ohio district judge in Chamber of Commerce’s suit. Only other IRA ruling to date dismissed PhRMA’s complaint on procedural grounds without addressing the merits.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT026156

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel